Rachel K. King
2019
In 2019, Rachel K. King earned a total compensation of $2.7M as President and Chief Executive Officer at GlycoMimetics, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $276,854 |
|---|---|
| Option Awards | $1,844,400 |
| Salary | $559,300 |
| Other | $8,519 |
| Total | $2,689,073 |
King received $1.8M in option awards, accounting for 69% of the total pay in 2019.
King also received $276.9K in non-equity incentive plan, $559.3K in salary and $8.5K in other compensation.
Rankings
In 2019, Rachel K. King's compensation ranked 4,537th out of 13,971 executives tracked by ExecPay. In other words, King earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,537 out of 13,971 | 68th |
Division Manufacturing | 1,693 out of 5,701 | 70th |
Major group Chemicals And Allied Products | 591 out of 2,200 | 73rd |
Industry group Drugs | 497 out of 1,886 | 74th |
Industry Pharmaceutical Preparations | 375 out of 1,398 | 73rd |
Source: SEC filing on April 16, 2020.
King's colleagues
We found two more compensation records of executives who worked with Rachel K. King at GlycoMimetics in 2019.